ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

TVTX Travere Therapeutics Inc

7,96
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 0
Prix Achat 7,57
Prix Vente 8,44
Actualités -
Maximum Haut

Bas
5,12

Sur 52 semaines

Haut
17,5699

Minimum Bas
Nom Action Symbole Action Marché Type
Travere Therapeutics Inc TVTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 7,96 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
7,96
Transactions Totales Volume échangé Volume en moyenne Sur 52 semaines
0 0 - 5,12 - 17,5699
Dernière Transaction Type Quantités échangées Prix transaction Devise
- 0 US$ 7,96 USD

Flux d'options Travere Therapeutics (TVTX)

Flux global

Baissier

Prime nette

-206k

Calls / Puts

0,00%

Ach. / Vent.

0,00%

OTM / ITM

0,00%

Sweeps Ratio

0,00%

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
605,99M 76,13M - 145,24M -111,4M -1,46 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Travere Therapeutics

Date Heure Source Titre
14/6/202422:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
11/6/202423:00GlobeNewswire Inc.Travere Therapeutics Reports Inducement Grants Under Nasdaq..
15/5/202423:00GlobeNewswire Inc.Travere Therapeutics Reports Inducement Grants Under Nasdaq..
13/5/202422:05Edgar (US Regulatory)Form 8-K - Current report
10/5/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:30GlobeNewswire Inc.Travere Therapeutics to Present at National Kidney..
08/5/202422:30GlobeNewswire Inc.Travere Therapeutics to Present at Upcoming Investor..

Forum Action Travere Therapeutics

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Travere Therapeutics Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine7,078,216,807,382 113 0650,8912,59%
1 mois6,608,216,497,331 165 1071,3620,61%
3 mois6,978,215,126,591 245 4260,9914,20%
6 mois9,2410,275,127,611 232 396-1,28-13,85%
1 an16,1017,56995,128,711 375 658-8,14-50,56%
3 ans15,8131,655,1216,391 098 534-7,85-49,65%
5 ans25,1533,08995,1217,071 024 660-17,19-68,35%